Aspect Partners’s Twist Bioscience TWST Stock Holding History

Aspect Partners’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-14	Closed	-$550	–	661
2025 Q1	$550	Buy	+14	New	+$631	﹤0.01%	537

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Aspect Partners's TWST Position: Q2 2025 in Review

Aspect Partners sold out of Twist Bioscience (TWST) in Q2 2025, closing a stake of 14 shares — an estimated $550 sold.

Aspect Partners first reported a position in TWST in Q1 2025 and held it in 1 quarter. The position peaked at $550 in Q1 2025. 243 funds tracked by Wall St. Rank hold TWST as of Q2 2025.

Aspect Partners reported no remaining Twist Bioscience position as of Q2 2025 after selling out during the quarter.
Aspect Partners sold 14 Twist Bioscience shares in Q2 2025, an estimated $550.
Aspect Partners first reported a position in Twist Bioscience in Q1 2025 and held it in 1 quarter.
Aspect Partners's Twist Bioscience position peaked at $550 in Q1 2025.
243 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2025.

Based on Aspect Partners's 13F filing for Q2 2025, filed 6 Aug 2025.